Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
Dr Pezalla suggests that a new generation of FDA-approved medications could help certain patients. Working with drug manufactures, Aetna has developed a personal 3-part weight loss pilot program which includes the promotion of employer-sponsored wellness programs, the development of the mobile health app “CarePass,” and providing patients with access to the preferred tier of their given pharmacy benefit plans.
Balancing Life and Myeloma: A Patient-Centered Approach
November 22nd 2024In this second part of our discussion with Don M. Benson, MD, PhD, from our recent Institute for Value-Based Medicine® event in Cleveland, Ohio, he explains how his ultimate goal for his patients is for them to live as long and as well as possible.
Read More
Intensive Blood Pressure Regimen Lowers CVD Risk for People With Diabetes
November 19th 2024Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with type 2 diabetes in the Blood Pressure Control Target in Diabetes trial.
Read More